IRIS UniCatt

Ricci, Caterina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.202
EU - Europa 1.093
AS - Asia 922
SA - Sud America 151
AF - Africa 26
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.399
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.171
SG - Singapore 419
IT - Italia 325
DE - Germania 235
CN - Cina 196
BR - Brasile 128
SE - Svezia 112
VN - Vietnam 101
FR - Francia 95
PL - Polonia 59
GB - Regno Unito 58
IN - India 52
FI - Finlandia 46
IE - Irlanda 35
UA - Ucraina 31
HK - Hong Kong 30
ID - Indonesia 28
RU - Federazione Russa 25
BD - Bangladesh 18
JP - Giappone 18
NL - Olanda 18
CA - Canada 16
KR - Corea 13
MX - Messico 12
AR - Argentina 11
AT - Austria 11
BE - Belgio 11
ZA - Sudafrica 10
ES - Italia 9
IQ - Iraq 8
IR - Iran 6
MA - Marocco 6
TR - Turchia 6
PK - Pakistan 5
RO - Romania 5
AU - Australia 4
CH - Svizzera 4
SA - Arabia Saudita 4
VE - Venezuela 4
EC - Ecuador 3
ET - Etiopia 3
IL - Israele 3
JO - Giordania 3
LT - Lituania 3
AE - Emirati Arabi Uniti 2
AW - Aruba 2
CI - Costa d'Avorio 2
HU - Ungheria 2
OM - Oman 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
BG - Bulgaria 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
PY - Paraguay 1
SI - Slovenia 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.399
Salva come PNG Salva come JPEG
Città #
Singapore 249
Ashburn 162
Chandler 131
San Jose 111
Rome 60
Warsaw 56
New York 49
Beijing 41
The Dalles 37
Dublin 35
Milan 33
Council Bluffs 32
Ho Chi Minh City 31
Hefei 29
Ann Arbor 28
Helsinki 28
Hanoi 27
Hyderabad 26
Jakarta 26
Los Angeles 26
Jacksonville 25
Lauterbourg 25
Hong Kong 23
San Mateo 21
Fairfield 20
Frankfurt am Main 20
Munich 19
Tokyo 18
Houston 17
Marseille 16
Wilmington 15
Moscow 14
Bremen 13
Nürnberg 13
Dearborn 12
Redwood City 12
Boston 11
Chicago 11
Nanjing 11
Orem 11
Santa Clara 11
Atlanta 10
Brussels 10
Düsseldorf 10
Pescara 10
Toronto 10
Woodbridge 10
Buffalo 9
Cambridge 9
Princeton 9
Seoul 9
São Paulo 9
Chennai 8
Dallas 8
Johannesburg 8
Turku 8
Washington 8
Kent 7
London 7
Paris 7
Seattle 7
Amsterdam 6
Brooklyn 6
Denver 6
Mexico City 6
Phoenix 6
Pisa 6
Vienna 6
Boardman 5
Busto Arsizio 5
Cattolica 5
Da Nang 5
Manchester 5
Portsmouth 5
Roubaix 5
Curitiba 4
Detroit 4
Guangzhou 4
Haiphong 4
Izmir 4
Lancaster 4
Lappeenranta 4
Madrid 4
Mcallen 4
New Haven 4
Nuremberg 4
Poplar 4
Ribeirão Preto 4
Stockholm 4
Allumiere 3
Amman 3
Asti 3
Baronissi 3
Cardiff 3
Changsha 3
Dhaka 3
Dong Ket 3
Elk Grove Village 3
Giulianova 3
Jeju City 3
Totale 1.894
Salva come PNG Salva come JPEG
Nome #
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence 314
NEOPLASIE DELLA VULVA E DELLA VAGINA 302
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. 188
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 188
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 180
Hpv and cytology testing in women undergoing 9-valent hpv opportunistic vaccination: A single-cohort follow up study 172
Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. 162
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments 159
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 148
Real-world management of trabectedin/pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian cancer patients: A national survey 137
Cancer and Mediterranean Diet: A Review 122
Recent progress in the use of pharmacotherapy for endometrial cancer 117
PARP Inhibitors Resistance: Mechanisms and Perspectives 115
Locally Advanced Cervical Cancer in Pregnancy 113
Advanced and recurrent endometrial cancer: State of the art and future perspectives 110
Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon? 105
Health utilities lost and risk factors associated with HPV-induced diseases in men and women: The HPV Italian collaborative study group 101
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 97
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer 94
Are we facing a new colposcopic practice in the HPV vaccination era? Opportunities, challenges, and new perspectives 90
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives 89
Colposcopy Accuracy and Diagnostic Performance: A Quality Control and Quality Assurance Survey in Italian Tertiary-Level Teaching and Academic Institutions—The Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV) 88
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 77
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 75
Long-term efficacy and safety of human papillomavirus vaccination 68
Major predictive factors for recurrence of CIN after treatment: an exploratory analysis towards a predictive model 37
Totale 3.448
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.754
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202166 0 0 0 0 0 0 0 0 0 0 51 15
2021/2022175 17 8 5 12 6 10 3 25 7 18 18 46
2022/2023449 48 56 22 64 21 63 23 30 62 17 30 13
2023/2024325 13 52 24 27 10 47 40 13 9 10 26 54
2024/2025605 24 6 61 22 47 24 35 21 65 105 118 77
2025/20261.277 160 33 69 142 230 88 260 85 120 89 1 0
Totale 3.448